Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.
The pharmaceutical company's MariTide treatment performs well in a phase 2 study but not as well as Wall Street expected.
Kohl's shares dive 20% as Q3 results miss estimates, guidance slashed
Kohl’s Corp (NYSE:KSS) shares plummeted nearly 20% in premarket trading Tuesday after the retailer reported disappointing third-quarter results and significantly lowered its full-year outlook, citing ...
The Grand Junction Daily Sentinel47m
Stock market today: Wall Street hangs near its records despite tariff talk
U.S. stocks are hanging around their records on Tuesday as Wall Street takes Donald Trump’s latest talk about tariffs in ...
Why Kohl's Stock Crashed 20% on Tuesday
Kohl's (NYSE: KSS) stock collapsed after the company reported mixed earnings for its fiscal third quarter of 2024 Tuesday ...
Fox Business51m
Kohl's shares tumble on earnings miss, CEO to step down in January
Michaels CEO Ashley Buchanan will take over the company on Jan. 15, though Kingsbury will stay on in an advisory role and ...
SchaeffersResearch.com59m
Kohl's Stock Eyes Worst Day Since 2020 After Earnings
KSS gapped to a fresh four-year low of $14.53 earlier, after running into familiar overhead pressure at the $19 level. Shares ...